Results 111 to 120 of about 2,021 (130)

Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention–sponsored Summit

Ca-A Cancer Journal for Clinicians, 2020
Samir Gupta, Gloria D Coronado, Alison T Brenner   +2 more
exaly  

Genetics, genomics, and cancer risk assessment

Ca-A Cancer Journal for Clinicians, 2011
Kenneth Offit
exaly  

MCED blood test boosts cancer detection in symptomatic patients

Ca-A Cancer Journal for Clinicians, 2023
exaly  

Multiple Myeloma: Charging Toward a Bright Future

Ca-A Cancer Journal for Clinicians, 2007
Parameswaran N Hari
exaly  

Cancer‐related risk factors and preventive measures in US Hispanics/Latinos

Ca-A Cancer Journal for Clinicians, 2012
Priti Bandi
exaly  

COVID concerns highlight the importance of adequate fecal immunochemical test sample collection

Ca-A Cancer Journal for Clinicians, 2021
exaly  

Cancer screening with multicancer detection tests: A translational science review

Ca-A Cancer Journal for Clinicians
Wendy S Rubinstein, Christos Patriotis
exaly  

Towards a point-of-care test for active tuberculosis: obstacles and opportunities

Nature Reviews Microbiology, 2011
Ruth McNerney, Peter Daley
exaly  

Cervical Cancer Screening Rates in the United States and the Potential Impact of Implementation of Screening Guidelines

Ca-A Cancer Journal for Clinicians, 2007
exaly  

Screening for Prostate Cancer

Ca-A Cancer Journal for Clinicians, 2009
exaly